Advertisement

Topics

End Brexit uncertainty for at-risk UK pharma sector, says cross-party committee

10:14 EDT 17 May 2018 | thePharmaLetter

A report concludes that the prospect of leaving the European Union (EU) without an agreement that protects…

Original Article: End Brexit uncertainty for at-risk UK pharma sector, says cross-party committee

NEXT ARTICLE

More From BioPortfolio on "End Brexit uncertainty for at-risk UK pharma sector, says cross-party committee"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...